Arkolith/Insider Trading/JNCE/Form 4

TRV GP III, LLC

10% OwnerJounce Therapeutics, Inc. (JNCE) · full profile →Form 4 · filed Nov 16, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$15.9M
Net Open-Market Flow
-$15.9M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 12, 2021Sell(S)1.9M$8.38$15.9M1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-044916) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML